Huntington's disease - neuropathology - PubMed (original) (raw)
Review
Huntington's disease - neuropathology
Jean Paul G Vonsattel et al. Handb Clin Neurol. 2011.
Abstract
An expansion of a trinucleotide CAG repeat on chromosome 4 causes Huntington disease. The abnormal elongation of the CAG increases the polyglutamine stretch of huntingtin, which becomes proportionally toxic. The mutated huntingtin is ubiquitous in somatic tissues, yet the pathologic changes are apparently restricted to the brain. The degree of the abnormal expansion of the CAG repeats governs the gradually diffuse atrophy of the brain. However, the brunt of the degenerative process involves the striatum. The onset of symptoms is insidious, but the longer the CAG expansion, the earlier their occurrence. They include psychiatric, motor, and cognitive disorders. Patients with adult onset of symptoms are more prone to exhibit choreic movements whereas those with juvenile onset tend to develop parkinsonism or rigidity. Brains from patients with juvenile onset are usually more atrophic than those with adult onset. Brains from patients with late onset of symptoms might show changes occurring in usual aging in addition to those characteristically observed in Huntington disease. Despite recent important discoveries, the pathogenesis of Huntington disease is still not elucidated. Many possible mechanisms underlying the relative selective vulnerability of neurons are being explored. In particular, factors promoting apoptosis, and phenomena causing the toxic aggregation of proteins, or the blockage of trophic factors, or mitochondria dysfunction, and excitoxicity have been studied.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
- CAG repeat number governs the development rate of pathology in Huntington's disease.
Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. Penney JB Jr, et al. Ann Neurol. 1997 May;41(5):689-92. doi: 10.1002/ana.410410521. Ann Neurol. 1997. PMID: 9153534 - Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, Vidailhet M, Legout A, Dodé C, Brice A, Dürr A. Ribaï P, et al. Arch Neurol. 2007 Jun;64(6):813-9. doi: 10.1001/archneur.64.6.813. Arch Neurol. 2007. PMID: 17562929 - [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N, Culjković B, Romac S, Stojković O, Sternić N, Sokić D, Kostić VS. Vojvodić N, et al. Srp Arh Celok Lek. 1998 Mar-Apr;126(3-4):77-82. Srp Arh Celok Lek. 1998. PMID: 9863360 Serbian. - [Huntington's disease: clinical and molecular genetics].
Warita H, Shiro Y, Kashihara K, Abe K. Warita H, et al. Nihon Rinsho. 1999 Apr;57(4):896-9. Nihon Rinsho. 1999. PMID: 10222786 Review. Japanese. - Juvenile onset Huntington's disease--clinical and research perspectives.
Nance MA, Myers RH. Nance MA, et al. Ment Retard Dev Disabil Res Rev. 2001;7(3):153-7. doi: 10.1002/mrdd.1022. Ment Retard Dev Disabil Res Rev. 2001. PMID: 11553930 Review.
Cited by
- Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
Estevez-Fraga C, Elmalem MS, Papoutsi M, Durr A, Rees EM, Hobbs NZ, Roos RAC, Landwehrmeyer B, Leavitt BR, Langbehn DR, Scahill RI, Rees G, Tabrizi SJ, Gregory S. Estevez-Fraga C, et al. Brain Behav. 2023 Apr;13(4):e2940. doi: 10.1002/brb3.2940. Epub 2023 Mar 14. Brain Behav. 2023. PMID: 36917716 Free PMC article. - A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients.
Liu P, Smith BR, Huang ES, Mahesh A, Vonsattel JPG, Petersen AJ, Gomez-Pastor R, Ashe KH. Liu P, et al. Acta Neuropathol Commun. 2019 Jul 30;7(1):111. doi: 10.1186/s40478-019-0764-9. Acta Neuropathol Commun. 2019. PMID: 31358058 Free PMC article. - Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, Di Pardo A, Holt A, Kerr BJ, Todd KG, Baker GB, Fouad K, Sipione S. Alpaugh M, et al. EMBO Mol Med. 2017 Nov;9(11):1537-1557. doi: 10.15252/emmm.201707763. EMBO Mol Med. 2017. PMID: 28993428 Free PMC article. - Post-mortem 7T MR imaging and neuropathology in middle stage juvenile-onset Huntington disease: A case report.
Bakels HS, van Duinen SG, de Bresser J, van Roon-Mom WMC, van der Weerd L, de Bot ST. Bakels HS, et al. Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12858. doi: 10.1111/nan.12858. Epub 2022 Nov 13. Neuropathol Appl Neurobiol. 2023. PMID: 36334065 Free PMC article. No abstract available. - Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases.
Duan L, Li X, Ji R, Hao Z, Kong M, Wen X, Guan F, Ma S. Duan L, et al. Polymers (Basel). 2023 May 5;15(9):2196. doi: 10.3390/polym15092196. Polymers (Basel). 2023. PMID: 37177342 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical